Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.020
-0.010 (-0.49%)
Sep 17, 2026, 4:10 PM AEST
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 396.06 million as of September 16, 2026. Its market cap has decreased by -0.92% in one year.
Market Cap
396.06M
Enterprise Value
361.77M
Revenue
2.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.02
ChartMarket Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 396.06M, an increase of 3,034.08%. That is a compound annual growth rate of 40.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 396.06M | -19.77% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 779.74M |
| Clinuvel Pharmaceuticals | 409.98M |
| Starpharma Holdings | 362.40M |
| Tetratherix | 345.41M |
| BLS Pharmaceuticals | 271.76M |
| Actinogen Medical | 200.85M |
| Orthocell | 187.91M |
| Nyrada | 180.38M |